Therefore, targeting TSHR is an optimal method to induce the redifferentiation of poorly differentiated carcinoma of the thyroid and increase the iodide uptake of iodine-refractory thyroid carcinomas by increasing the NIS expression [144]. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.